当前位置：药药网 / 数据中心 / 生物制药海外临床研究状况
Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV
标题（英文）
Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV
条件
HPV Positive Oropharyngeal Squamous Cell Carcinoma|HIV-1-infection|HPV Infection
干预
Biological: 9 valent human papillomavirus vaccine (Types 6, 11, 16, 18, 31, 33, 45, 52, 58)|Other: Saline Placebo